At Tercica, the depth of our commitment to endocrine and metabolic health compels us to continually seek out more effective treatment options. To that end, we maintain a steady stream of products in our pipeline, all at various stages of development. In some cases, we are working with the research community to explore new specialty indications for existing products. In others, we are partnering with other biopharmaceutical organizations to develop and commercialize new products. Ongoing clinical trials allow us to evaluate the safety and efficacy of new products prior to commercialization, while patient registries enable us to track real-world data on patients who are currently prescribed therapies we have already brought to market. As we move toward a future in which the average life expectancy increases, Tercica will be there with high-value products that help people to live fuller, healthier lives.